v3.26.1
Segment Reporting
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting
Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker (CODM) in making decisions regarding resource allocation and assessing performance. The Company views its operations as, and manages its business in, one operating segment focused on the design, development and commercialization of testing products which allow for the differential diagnosis, prognosis and monitoring of complex rheumatic, autoimmune and autoimmune-related disease. Segment revenue is primarily derived from the sale of the Company’s testing products, most of which is attributable to its AVISE® CTD test.
The Company’s CODM is its Chief Executive Officer. The CODM assesses performance for the segment and decides how to allocate resources based on revenue and net loss as reported on the condensed statements of operations, after taking into account the Company’s strategic priorities, its cash balance and its expected use of cash. The CODM considers budget/forecast versus actual results on a quarterly basis when making decisions about the allocation of resources. The measure of segment assets is reported on the balance sheet as total assets and were $51.9 million and $58.0 million as of June 30, 2026 and December 31, 2025, respectively.
Segment revenue and net loss, including significant segment expenses regularly provided to the CODM are as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Revenue$19,941 $17,202 $37,247 $32,700 
Cost of revenue7,724 6,807 14,825 13,182 
Gross profit12,217 10,395 22,422 19,518 
Segment operating expenses:
Employee expense8,154 7,535 16,562 15,083 
Outside services1,550 1,347 2,753 2,464 
Facilities related1,038 918 1,917 1,818 
Travel & entertainment779 715 1,456 1,451 
Stock compensation918 384 1,525 745 
Depreciation and amortization235 270 465 529 
Other1
1,265 1,856 2,880 3,423 
Total segment operating expenses13,939 13,025 27,558 25,513 
Loss from operations(1,722)(2,630)(5,136)(5,995)
Interest expense(1,201)(1,124)(2,468)(1,669)
Loss on extinguishment of debt— (295)— (295)
Change in fair value of warrant liability(426)(438)456 (438)
Other income (expense), net153 85 21 243 
Loss before income taxes$(3,196)$(4,402)$(7,127)$(8,154)
Income tax expense— (37)(36)(37)
Segment net loss$(3,196)$(4,439)$(7,163)$(8,191)
1Other segment items included in Segment operating expenses include insurance expenses, trade show and conference expenses, fulfillment expenses, board compensation, clinical trial expenses, collaboration expenses and bank fees, among others.